Molecular signatures of vascular injury are associated with early growth of intracerebral hemorrhage

Stroke

Volumn 36, Issue 1, 2005, Pages 86-91

  Silva, Yolanda ^a   Leira, Rogelio ^b   Tejada, Javier ^c   Lainez, José M ^d   Castillo, José ^b   Dávalos, Antoni ^a  

^a HOSPITAL JOSEP TRUETA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c Hospital Virgen Bianca   (Spain)

^d HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

Blood brain barrier; Computed tomography; Hematoma; Inflammation; Intracerebral hemorrhage; Outcome; Prognosis

Indexed keywords

FIBRINOGEN; FIBRONECTIN; GELATINASE B; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD BRAIN BARRIER; BLOOD VESSEL INJURY; BRAIN HEMORRHAGE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOTHELIUM INJURY; FEMALE; FIBRINOGEN BLOOD LEVEL; HEMATOMA; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL; THROMBOCYTE COUNT;

AGED; BIOLOGICAL MARKERS; CEREBRAL HEMORRHAGE; CYTOKINES; FEMALE; FIBRONECTINS; HEMATOMA; HUMANS; INTERLEUKIN-6; MALE; MATRIX METALLOPROTEINASE 9; PROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 11144234974     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000149615.51204.0b     Document Type: Article

References (32)

1. Kazui S, Naritomi H, Yamamoto H, Sawada T, Yamaguchi T. Enlargement of spontaneous intracerebral hemorrhage. Incidence and time course. Stroke. 1996;27:1783-1787.
2. Brott T, Broderick J, Kothari R, Barsan W, Tomsick T, Sauerbeck L, Spilker J, Duldner J, Khouri J. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke. 1997;28:1-5.
3. Fujii Y, Tanaka R, Takeuchi S, Koike T, Minakawa T, Sasaki O. Hematoma enlargement in spontaneous intracerebral hemorrhage. J Neurosurg. 1994;80:51-57.
4. Mayer Sa, Lignelli A, Fink ME, Kessler DB, Thomas CE, Swarup R, Van Heertum RL. Perilesional blood flow and edema formation in acute intracerebral hemorrhage: a SPECT study. Stroke. 1998;29: 1791-1798.
5. Mendelow AD. Mechanisms of ischemic brain damage with intracerebral hemorrgae. Stroke. 1993;24(suppl 1):115-117.
6. Lee KR, Kawai N, Seoung K, Sagher O, Hoff JT. Mechanisms of edema formation after intracerebral hemorrhage: effects of thrombin on cerebral blood flow, blood brain barrier permeability and cell survival in a rat model. J Neurosurg. 1997;86:272-278.
7. Xi G, Wagner KR, Keep RF, Hua Y, de Courten-Mayers G, Broderick JP, Brott TG, Hoff JT. Role of blood clot formation on early edema development after experimental intracerebral hemorrhage. Stroke. 1998;29:2580-2586.
8. Rosenberg GA, Navratil M. Metalloproteinase inhibition blocks edema in intracerebral hemorrhage in the rat. Neurology. 1997;48: 921-926.
9. Castillo J, Davalos A, Alvarez-Sabin J, Pumar JM, Leira R, Silva Y, Montaner J, Kase CS. Molecular signatures of brain injury after intracerebral hemorrhage. Neurology. 2002;58:624-629.
10. Abilleira S, Montaner J, Molina C, Monasterio J, Castillo J, Alvarez-Sabín J. Matrix metalloproteinase-9 concentration alter spontaneous intracerebral hemorrhage. J Neurosurg. 2003;99:65-70.
11. Makogonenko E, Tsurupa G, Ingham K, Medved L. Interaction of fibrin(ogen) with fibronectine: further characterization and localization of the fibronectin-binding site. Biochemistry. 2002;41: 7907-7913.
12. Castellanos M, Leira R, Serena J, Pumar JM, Lizasoain I, Castillo J, Davalos A. Plasma metalloproteinase-9 concentration predicts hemorrhagic transformation in acute ischemic stroke. Stroke. 2004;35: 1671-1676.
13. Castellanos M, Leira R, Serena J, Blanco M, Pedraza S, Castillo J, Davalos A. Plasma cellular-fibronectin concentration predicts hemorrhagic transformation after thrombolytic therapy in acute ischemic stroke.
14. Leira R, Dávalos A, Silva Y, Gil-Peralta A, Tejada J, Garcia M, Castillo J. Predictors and associated factors of early neurological deterioration in intracerebral hemorrhage. Neurology. 2004; 63:461-467.
15. Cote R, Battista RN, Wolfson C, Boucher J, Adam J, Hachinski V. The Canadian Neurological Scale: validation and reliability assessment. Neurology. 1989;39:638-643.
16. Láinez JM, Pareja A, Martí-Fábregas J, Leira R. Guía de actuación clínica en la hemorragia cerebral. Neurología. 2002;17(suppl 3):76-86. [In Spanish].
17. Dávalos A, Cendra E, Teruel J, Martínez M, Genís D. Deteriorating ischemic stroke: risk factors and prognosis. Neurology. 1990;40: 1865-1869.
18. Roberts C, Vermont J, Bosson JL. Formulas for thershold computations. Comput Biomed Res. 1991;24:514-529.
19. Lee KR, Colon GP, Betz AL, Keep RF, Kim S, Hoff JT. Edema from intracerebral hemorrhage: the role of thrombin. J Neurosurg. 1996;84:91-96.
20. Xi G, Hua Y, Bhasin RR, Ennis SR, Keep RF, Hoff JT. Mechanisms of edema formation after intracerebral hemorrhage. Effects of extravasated red blood cells on blood flow and blood-brain barrier integrity. Stroke. 2001;32:2932-2938.
21. Suzuki S, Kelley RE, Dandapani BK, Reyes-Iglesias Y, Dietrich WD, Duncan RC. Acute leukocyte and temperature response in hypertensive intracerebral hemorrhage. Stroke. 1995;26:1020-1023.
22. Margaglione M, Grandone E, Mancini FP, Di Minno G. Genetic modulation of plasma fibrinogen concentrations: possible importance of interleukine-6. J Thromb Thrombolysis. 1996;3:51-56.
23. Hamman GF, Okada Y, Fitridge R, Del Zoppo GJ. Microvascular basal lamina antigens disappear during cerebral ischemia and reperfusion. Stroke. 1995;26:2120-2126.
24. Horstmann S, Kalb P, Koziol J, Gardner H, Wagner S. Profiles of matrix metalloproteinases, their inhibitors, and laminin in stroke patients. Influence of different therapies. Stroke. 2003;34:2165-2172.
25. Aoki T, Sumii T, Mori T, Wang X, Lo EH. Blood-brain barrier disruption and matrix metalloproteinase-9 expression during reperfusion injury. Mechanical versus embolic focal ischemia in spontaneously hypertensive rats. Stroke. 2002;33:2711-2717.
26. Forsyth KD, Levinsky RJ. Fibronectin degradation: an in-vitro model of neutrophil mediated endothelial cell damage. J Pathol. 1990;161: 313-319.
27. Vartio T, Laitinen L, Narvanen O, Cutolo M, Thornell LE, Zardi L, Virtanen I. Differential expression of the ED sequence-containing form of cellular fibronectin in embryonic and adult human tissues. J Cell Sci. 1987;88:419-430.
28. Peters JH, Maunder RJ, Woolf AD, Cochrane GH, Ginsberg MH. Elevated plasma levels of ED1+ ("cellular") fibronectin in patients with vascular injury. J Lab Clin Med. 1989;113:586-597.
29. Kanters SD, Banga JD, Algra A, Frijns RC, Beutler JJ, Fijnheer R. Plasma levels of cellular fibronectin in diabetes. Diabetes Care. 2000; 24:323-327.
30. Hynes RO. Fibronectins. Sci Am. 1986;254:42-51.
31. La Fleur M, Beaulieu AD, Kreis C, Poubelle P. Fibronectin gene expression in polymorphonuclear leukocytes. Accumulation of mRNA in inflammatory cells. J Biol Chem. 1987;262:2111-2115.
32. Roberts CJ, Birkenmeier TM, McQuillan JJ et al. Transforming growth factor β stimulates the expression of fibronectin and of both subunits of the human fibronectin receptor by cultured human lung fibroblasts. J Biol Chem. 1988;263:4586-4592.